Erratum: Assessment of fractionated exhaled nitric oxide as a biomarker for the treatment of eosinophilic esophagitis. | Walter W. Chan, MD, MPH, FACG, AGAF - Harvard University

Leung J, Nguyen-Traxler A, Lee EM, et al. Erratum: Assessment of fractionated exhaled nitric oxide as a biomarker for the treatment of eosinophilic esophagitis. Allergy and asthma proceedings. 2013;34(1):107.

Publisher's Version

Last updated on 01/17/2023
PubMed